We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Increase in services provided in 2023 by all sequencing platforms, excluding COVID-related activities Positive EBITDA for the third year running, despite inflation impacting reagent costs SeqOIA...
Significant reduction of COVID-19 related activities Growth of all other lines of business Cash totaling €2.9m on Dec 31st, 2023 Laboratory in Évry accredited by the College of American...
Résilience de la rentabilité malgré le contexte inflationniste Croissance des activités aux laboratoires d’Évry Regulatory News: IntegraGen (FR0010908723 – ALINT – Eligible PEA PME...
Baisse de l’activité de la plateforme de séquençage en microbiologie après une forte contribution enregistrée au 1er semestre 2022 dans le cadre de la pandémie de Covid-19. Retraitée de cet...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.025 | -4.13223140496 | 0.605 | 0.64 | 0.58 | 1677 | 0.60506263 | DE |
4 | -0.13 | -18.3098591549 | 0.71 | 0.86 | 0.58 | 5013 | 0.69331092 | DE |
12 | -0.168 | -22.4598930481 | 0.748 | 0.93 | 0.58 | 5458 | 0.7710929 | DE |
26 | -0.386 | -39.9585921325 | 0.966 | 1.05 | 0.58 | 4140 | 0.79772507 | DE |
52 | -0.62 | -51.6666666667 | 1.2 | 1.57 | 0.58 | 3434 | 1.00302512 | DE |
156 | -1.35 | -69.9481865285 | 1.93 | 2.04 | 0.58 | 4848 | 1.30388647 | DE |
260 | -0.94 | -61.8421052632 | 1.52 | 2.67 | 0.58 | 35596 | 1.66800826 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions